Patents by Inventor Michel Lanotte

Michel Lanotte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Identification and use of miRNAs for differentiating myeloid leukemia cells
    Publication number: 20090029932
    Abstract: The invention relates to the use of nucleic acid miRNA derived molecules for producing a drug for treating a myelogenous leukemia and to a method for identifying therapeutic agents or the efficient combination thereof for inducing the differentiation of myelogenous leukemia cells.
    Type: Application
    Filed: May 3, 2007
    Publication date: January 29, 2009
    Applicant: Centre National De La Recherche Scientifique (CNRS)
    Inventors: Olivier Voinnet, Charles-Henri Lecellier, Anne Saumet, Michel Lanotte
  • Compositions and methods for treatment of hyperproliferative diseases
    Patent number: 6624154
    Abstract: The invention relates to compositions comprising a retinoid X receptor agonist and an agent capable of activating protein kinase A. The invention also relates to methods of treating hyperproliferative diseases by administering a retinoid X receptor agonist and an agent capable of activating protein kinase A.
    Type: Grant
    Filed: April 21, 2000
    Date of Patent: September 23, 2003
    Assignees: Bristol-Myers Squibb Company, Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, Universite Louis Pasteur
    Inventors: Gérard Benoit, Hinrich Gronemeyer, Michel Lanotte, Marco Gottardis
  • Sterilization cell
    Patent number: 5712894
    Abstract: A gamma radiation cell for sterilizing industrial products, of the type constituted by a shielded enclosure provided with at least one tight access door, comprising an overhead conveyor for displacing transports supporting the products to be treated. The floor of the enclosure comprises a central well allowing storage of a source of irradiation which may be moved vertically. Pipes connect this well to an oxygen reserve and to a reservoir for storing the ozone produced by radiolysis, this ozone being able to be admitted into the vessel of the transports.
    Type: Grant
    Filed: November 28, 1995
    Date of Patent: January 27, 1998
    Inventor: Michel Lanotte
  • Cultures of permanent lines of human promyelocytic cells and their uses for the screening of molecules utilizable in particular in the treatment of leukemias
    Patent number: 5589345
    Abstract: The invention concerns permanent cell lines of human promyelocyte cells characteristic of acute promyelocytic leukemias, these cells being cytogenetically characterized by a translocation t(15;17), capable of indefinite proliferation in a culture medium. It also concerns the use of these cell lines, particularly for screening molecules capable of inducing cell maturation.
    Type: Grant
    Filed: December 17, 1993
    Date of Patent: December 31, 1996
    Assignee: Institut National de la Sante et de la Recherche Medicale
    Inventors: Michel Lanotte, Roland Berger